111 related articles for article (PubMed ID: 20074796)
1. Contribution of the central dopaminergic system in the anti-hypertensive effect of kinin B1 receptor antagonists in two rat models of hypertension.
De Brito Gariepy H; Carayon P; Ferrari B; Couture R
Neuropeptides; 2010 Apr; 44(2):191-8. PubMed ID: 20074796
[TBL] [Abstract][Full Text] [Related]
2. Brain kinin B₁ receptor contributes to the onset of stereotypic nocifensive behavior in rat.
De Brito Gariepy H; Talbot S; Sénécal J; Couture R
Behav Brain Res; 2013 Mar; 241():17-26. PubMed ID: 23219968
[TBL] [Abstract][Full Text] [Related]
3. The role of bradykinin B1 receptor on cardiac remodeling in stroke-prone spontaneously hypertensive rats (SHR-SP).
Moniwa N; Agata J; Hagiwara M; Ura N; Shimamoto K
Biol Chem; 2006 Feb; 387(2):203-9. PubMed ID: 16497153
[TBL] [Abstract][Full Text] [Related]
4. Involvement of kinin B1 receptor and oxidative stress in sensory abnormalities and arterial hypertension in an experimental rat model of insulin resistance.
Lungu C; Dias JP; França CE; Ongali B; Regoli D; Moldovan F; Couture R
Neuropeptides; 2007 Dec; 41(6):375-87. PubMed ID: 17988733
[TBL] [Abstract][Full Text] [Related]
5. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
6. Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure.
Reaux A; Iturrioz X; Vazeux G; Fournie-Zaluski MC; David C; Roques BP; Corvol P; Llorens-Cortes C
Biochem Soc Trans; 2000; 28(4):435-40. PubMed ID: 10961935
[TBL] [Abstract][Full Text] [Related]
7. Central effects of quinpirole on blood pressure of spontaneously hypertensive rats.
van den Buuse M
J Pharmacol Exp Ther; 1992 Jul; 262(1):303-11. PubMed ID: 1352551
[TBL] [Abstract][Full Text] [Related]
8. A-4, a tertiary amine analog of HC-3, lowers arterial pressure in spontaneously hypertensive rats.
Ozkutlu U; Shaffer RA; Lewis SJ; Long JP
J Pharmacol Exp Ther; 1996 Jun; 277(3):1352-8. PubMed ID: 8667197
[TBL] [Abstract][Full Text] [Related]
9. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease.
Prediger RD; Medeiros R; Pandolfo P; Duarte FS; Passos GF; Pesquero JB; Campos MM; Calixto JB; Takahashi RN
Neuroscience; 2008 Feb; 151(3):631-43. PubMed ID: 18191900
[TBL] [Abstract][Full Text] [Related]
10. Prolonged central effects of quinpirole on cardiovascular regulation.
van den Buuse M; Morton SJ; Cornish JL; Head GA
J Pharmacol Exp Ther; 1996 Apr; 277(1):473-83. PubMed ID: 8613956
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of dopaminergic drugs on open-field behavior of spontaneously hypertensive rats and normotensive Wistar-Kyoto rats.
van den Buuse M; de Jong W
J Pharmacol Exp Ther; 1989 Mar; 248(3):1189-96. PubMed ID: 2564890
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic and autoradiographic evidence for an up-regulation of kinin B(2) receptors in the spinal cord of spontaneously hypertensive rats.
Cloutier F; de Sousa Buck H; Ongali B; Couture R
Br J Pharmacol; 2002 Apr; 135(7):1641-54. PubMed ID: 11934804
[TBL] [Abstract][Full Text] [Related]
13. Secretory dysfunction of vascular endothelium limits the effect of angiotensin converting enzyme inhibitor quinapril on aggregation of erythrocytes in experimental hypertension.
Korbut RA; Madej J; Adamek-Guzik T; Korbut R
J Physiol Pharmacol; 2003 Sep; 54(3):397-408. PubMed ID: 14566078
[TBL] [Abstract][Full Text] [Related]
14. Role of brain cholinergic system in the antihypertensive effect of clonidine in different models of rat hypertension.
Squadrito F; Quattrone G; Buemi M; Frisina N; Caputi AP; Squadrito G
J Hypertens Suppl; 1985 Dec; 3(4):S97-9. PubMed ID: 3868718
[TBL] [Abstract][Full Text] [Related]
15. Renal protective role of bradykinin B1 receptor in stroke-prone spontaneously hypertensive rats.
Hagiwara M; Murakami H; Ura N; Agata J; Yoshida H; Higashiura K; Shimamoto K
Hypertens Res; 2004 Jun; 27(6):399-408. PubMed ID: 15253105
[TBL] [Abstract][Full Text] [Related]
16. Chronic nicotine administration. Analysis of the development of hypertension and glutamatergic neurotransmission.
Ferrari MF; Fior-Chadi DR
Brain Res Bull; 2007 May; 72(4-6):215-24. PubMed ID: 17452284
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
De Godoy MA; Rattan S
J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
[TBL] [Abstract][Full Text] [Related]
18. Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats.
Cloutier F; Ongali B; Campos MM; Thibault G; Neugebauer W; Couture R
Br J Pharmacol; 2004 May; 142(2):285-96. PubMed ID: 15066903
[TBL] [Abstract][Full Text] [Related]
19. Levels of brain angiotensin in the spontaneously hypertensive rat and treatment with ramiprilat.
Phillips MI; Kimura BK
J Hypertens Suppl; 1986 Dec; 4(6):S391-4. PubMed ID: 3475423
[TBL] [Abstract][Full Text] [Related]
20. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
Millan MJ; Newman-Tancredi A; Brocco M; Gobert A; Lejeune F; Audinot V; Rivet JM; Schreiber R; Dekeyne A; Spedding M; Nicolas JP; Peglion JL
J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
